These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 1709368

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Recombinant human granulocyte-macrophage colony-stimulating factor ameliorates zidovudine-induced neutropenia in patients with acquired immunodeficiency syndrome (AIDS)/AIDS-related complex.
    Levine JD, Allan JD, Tessitore JH, Falcone N, Galasso F, Israel RJ, Groopman JE.
    Blood; 1991 Dec 15; 78(12):3148-54. PubMed ID: 1742482
    [Abstract] [Full Text] [Related]

  • 3. Effects of recombinant human granulocyte colony-stimulating factor on leucopenia in zidovudine-treated patients with AIDS and AIDS related complex, a phase I/II study.
    van der Wouw PA, van Leeuwen R, van Oers RH, Lange JM, Danner SA.
    Br J Haematol; 1991 Jul 15; 78(3):319-24. PubMed ID: 1714756
    [Abstract] [Full Text] [Related]

  • 4. Haematopoietic growth factors as supportive therapy in HIV-infected patients.
    Hermans P.
    AIDS; 1995 Dec 15; 9 Suppl 2():S9-S14. PubMed ID: 8775801
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with AIDS.
    Kimura S, Matsuda J, Ikematsu S, Miyazono K, Ito A, Nakahata T, Minamitani M, Shimada K, Shiokawa Y, Takaku F.
    AIDS; 1990 Dec 15; 4(12):1251-5. PubMed ID: 1708265
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The use of hematopoietic growth factors in HIV infection and AIDS-related malignancies.
    Miles SA.
    Cancer Invest; 1991 Dec 15; 9(2):229-38. PubMed ID: 1713806
    [Abstract] [Full Text] [Related]

  • 8. A phase I/II trial of zidovudine, interferon-alpha, and granulocyte-macrophage colony-stimulating factor in the treatment of human immunodeficiency virus type 1 infection.
    Davey RT, Davey VJ, Metcalf JA, Zurlo JJ, Kovacs JA, Falloon J, Polis MA, Zunich KM, Masur H, Lane HC.
    J Infect Dis; 1991 Jul 15; 164(1):43-52. PubMed ID: 1676045
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Potential use of human stem cell factor as adjunctive therapy for human immunodeficiency virus-related cytopenias.
    Miles SA, Lee K, Hutlin L, Zsebo KM, Mitsuyasu RT.
    Blood; 1991 Dec 15; 78(12):3200-8. PubMed ID: 1720698
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. The Protocol 043 Study Group.
    McKinney RE, Maha MA, Connor EM, Feinberg J, Scott GB, Wulfsohn M, McIntosh K, Borkowsky W, Modlin JF, Weintrub P.
    N Engl J Med; 1991 Apr 11; 324(15):1018-25. PubMed ID: 1672443
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Maintenance treatment of the anemia of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor and erythropoietin: evidence for in vivo synergy.
    Negrin RS, Stein R, Doherty K, Cornwell J, Vardiman J, Krantz S, Greenberg PL.
    Blood; 1996 May 15; 87(10):4076-81. PubMed ID: 8639764
    [Abstract] [Full Text] [Related]

  • 17. GM-CSF as an alternative to dose modification of the combination zidovudine and interferon-alpha in the treatment of AIDS-associated Kaposi's sarcoma.
    Scadden DT, Bering HA, Levine JD, Bresnahan J, Evans L, Epstein C, Groopman JE.
    Am J Clin Oncol; 1991 May 15; 14 Suppl 1():S40-4. PubMed ID: 2048563
    [Abstract] [Full Text] [Related]

  • 18. Subcutaneous recombinant granulocyte-macrophage colony-stimulating factor used as a single agent and in an alternating regimen with azidothymidine in leukopenic patients with severe human immunodeficiency virus infection.
    Pluda JM, Yarchoan R, Smith PD, McAtee N, Shay LE, Oette D, Maha M, Wahl SM, Myers CE, Broder S.
    Blood; 1990 Aug 01; 76(3):463-72. PubMed ID: 2198957
    [Abstract] [Full Text] [Related]

  • 19. [Recombinant granulocyte colony-stimulating factor in the long-term treatment of AIDS-related neutropenias].
    Garavelli PL, Berti P.
    Recenti Prog Med; 1993 Aug 01; 84(7-8):526-30. PubMed ID: 8356307
    [Abstract] [Full Text] [Related]

  • 20. Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS).
    Krown SE, Gold JW, Niedzwiecki D, Bundow D, Flomenberg N, Gansbacher B, Brew BJ.
    Ann Intern Med; 1990 Jun 01; 112(11):812-21. PubMed ID: 1971504
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.